[VRTX] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
15-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -6.42%
YoY- 18.31%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 2,517,700 2,302,700 2,072,600 1,627,820 1,413,265 870,106 651,634 25.25%
PBT 1,147,600 1,076,800 870,900 888,623 676,950 32,497 112,442 47.25%
Tax 178,800 257,900 100,800 284,433 93,716 -1,492,599 10,257 60.98%
NP 968,800 818,900 770,100 604,190 583,234 1,550,527 100,684 45.81%
Tax Rate -15.58% -23.95% -11.57% -32.01% -13.84% 4,593.04% -9.12% -
Total Cost 1,548,900 1,483,800 1,302,500 1,023,630 830,031 -680,421 550,950 18.79%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 38.48 35.56 37.16 37.12 41.27 178.20 15.45 16.41%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 3.76 3.19 3.02 2.32 2.26 6.08 0.40 45.24%
EPS Diluted 3.71 3.15 3.00 2.30 2.23 5.97 0.39 45.53%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.